Similar Items: Burden of Invasive Pneumococcal Disease and Community-Acquired Pneumonia in Adults: Significant Adverse Outcomes and Costs beyond Direct Treatment
- Economic Evaluation of PCV21 Use in Populations with Increasing Serotype 4 Invasive Pneumococcal Disease in the US: An Attributable Fraction Threshold Analysis
- Association Between Pneumonia Risk and Anticholinergic Burden Among Patients with Different Frailty Levels [Response to Letter]
- Bordetella pertussis pneumonia in adults: two case reports and diagnostic challenges
- Comparison of Human Metapneumovirus and Respiratory Syncytial Virus-associated health burden in adults living with chronic underlying health conditions: a global systematic review and meta-analysis
- Development and rapid identification of a self-constructed MALDI-TOF MS library for Mycoplasma pneumoniae clinical isolates
- Ventilator-Associated Pneumonia Due to ESBL-Producing Successfully Treated with Cefepime/Enmetazobactam: A European Case Report